Items Tagged ‘aspire’

December 7th, 2014

ASH 2014: Kyprolis®-Based Treatment Demonstrates Significant Advance in the Treatment of Multiple Myeloma


Results of the phase 3 clinical trial ASPIRE were presented at the American Society of Hematology Meetings this week. Relapsed multiple myeloma patients treated with Kyprolis® (carfilzomib) in combination with Revlimid® (lenalidomide) and low-dose dexamethasone lived significantly longer without their disease worsening compared to patients treated with Revlimid®and low-dose dexamethasone. Multiple myeloma is a cancer […]

View full entry

Tags: aspire, kyprolis, Multiple Myeloma, News, Recurrent Multiple Myeloma